J-30
J-30 is an orally active and potent tubulin inhibitor (IC50=15-20 nM) . J-30 disrupts microtubule polymerization and induces G2/M phase arrest. J-30 is promising for research of solid tumors (e.g., gastric, oral) [1].
Product Specifications
CAS Number
[916484-16-7]
UNSPSC
12352005
Target
Microtubule/Tubulin
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Field of Research
Cancer
Smiles
O=C(C1=CC=NC=C1)NC2=CC=CC3=C2N(CC3)S(=O)(C4=CC=C(C=C4)OC)=O
Molecular Formula
C21H19N3O4S
Molecular Weight
409.46
References & Citations
[1]Liou JP, et al. A novel oral indoline-sulfonamide agent, N-[1- (4-methoxybenzenesulfonyl) -2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. J Pharmacol Exp Ther. 2007 Oct;323 (1) :398-405.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
303470-HRP 100 µL
MUC2 (Intestinal Mucin 2, MLP, MUC 2, MUC-2, Muc2, MUC2_HUMAN, Mucin 2, Mucin 2 Intestinal, Intestinal Mucin-2, Mucin 2 Intestinal/Tracheal, Mucin 2 Oligomeric Mucus/Gel Forming, Mucin 2 Precursor, Mucin 2 Tracheal, Mucin Like Protein, Mucin-2, Mucin2, SMUC) (HRP) discontinued
Ask
View Details 